Technology area: Biotechnology & Pharmaceuticals
7 pending office actions • 5 art units • 6 examiners • 0 of 7 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
Medizinische Hochschule Hannover has 7 pending office actions in Biotechnology & Pharmaceuticals. The docket spans 6 examiners and 5 art units, indicating substantial distribution across the examination structure with some concentration at the examiner level.
PENNINGTON, KATIE LEIGH is the busiest examiner, with 2 pending matters. Counsel should coordinate positions across the portfolio and compare the two matters assigned to that examiner, while tailoring responses to the distinct technical records in the other files.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (43%) |
| §103 only | 2 (29%) |
| §112 only | 1 (14%) |
| Multi-statute (no §101) | 1 (14%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PENNINGTON, KATIE LEIGH | 2 | 31.8% | +58.8% |
| SPENCE, JENNIFER SUZANNE | 1 | 66.9% | +46.0% |
| CORNELIUS, CLAIRE ADRIENNE | 1 | 71.4% | +0.0% |
| YU, DELPHINUS DOU YI | 1 | 33.3% | +0.0% |
| GONZALES, JOSEPHINE MARIA | 1 | 28.8% | +34.6% |
| WEHBE, ANNE MARIE SABRINA | 1 | 57.3% | +43.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18720993 | ALPHARETROVIRUS-BASED PARTICLES FOR DELIVERY OF RNA INTO CELLS | SPENCE, JENNIFER SUZANNE | — |
| 18289787 | GLYCOPROTEINS FOR PSEUDOTYPING RETROVIRAL VECTOR PARTICLES | CORNELIUS, CLAIRE ADRIENNE | — |
| 18010340 | PROCESS FOR PRODUCING LIVER CELLS | GONZALES, JOSEPHINE MARIA | — |
| 17605180 | ARTIFICIAL SIGNALLING MOLECULE | WEHBE, ANNE MARIE SABRINA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17615453 | COMPOSITIONS AND PROCESS FOR INTEGRATING CELLS INTO EPITHELIUM | PENNINGTON, KATIE LEIGH | 99d overdue |
| 17800338 | Viral vector particle based on AA V2 for gene therapy | PENNINGTON, KATIE LEIGH | 17d overdue |
| 18720993 | ALPHARETROVIRUS-BASED PARTICLES FOR DELIVERY OF RNA INTO CELLS | SPENCE, JENNIFER SUZANNE | — |
| 18010340 | PROCESS FOR PRODUCING LIVER CELLS | GONZALES, JOSEPHINE MARIA | — |
| 17605180 | ARTIFICIAL SIGNALLING MOLECULE | WEHBE, ANNE MARIE SABRINA | — |
| Art Unit | Apps |
|---|---|
| 1634 | 3 |
| 1633 | 1 |
| 1672 | 1 |
| 1636 | 1 |
| 1631 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18720993 | ALPHARETROVIRUS-BASED PARTICLES FOR DELIVERY OF RNA INTO CELLS | SPENCE, JENNIFER SUZANNE | 1633 | §101§103§112 | Non-Final OA | — | Pending | Jun 17, 2024 |
| 18289787 | GLYCOPROTEINS FOR PSEUDOTYPING RETROVIRAL VECTOR PARTICLES | CORNELIUS, CLAIRE ADRIENNE | 1672 | §101§102§103§112 | Non-Final OA | — | Pending | Nov 07, 2023 |
| 18254669 | LENTIVIRAL VECTOR TECHNOLOGY FOR INNER EAR GENE THERAPY | YU, DELPHINUS DOU YI | 1636 | §103 | Final Rejection | — | Pending | May 26, 2023 |
| 18010340 | PROCESS FOR PRODUCING LIVER CELLS | GONZALES, JOSEPHINE MARIA | 1631 | §101§103§112 | Final Rejection | — | Pending | Dec 14, 2022 |
| 17800338 | Viral vector particle based on AA V2 for gene therapy | PENNINGTON, KATIE LEIGH | 1634 | §112 | Final Rejection | 17d overdue | Pending | Aug 17, 2022 |
| 17615453 | COMPOSITIONS AND PROCESS FOR INTEGRATING CELLS INTO EPITHELIUM | PENNINGTON, KATIE LEIGH | 1634 | §103 | Non-Final OA | 99d overdue | Pending | Nov 30, 2021 |
| 17605180 | ARTIFICIAL SIGNALLING MOLECULE | WEHBE, ANNE MARIE SABRINA | 1634 | §103§112 | Non-Final OA | — | Pending | Oct 20, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMedizinische Hochschule Hannover has 7 pending office actions as of October 2026, spread across 5 art units and 6 examiners.
Katie Leigh Pennington has the most, with 2 of Medizinische Hochschule Hannover's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
